ArticleNature communications2018

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.

Ivana Zagorac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.